Literature DB >> 12490710

Characterisation of the DNA-dependent ATPase activity of human DNA topoisomerase IIbeta: mutation of Ser165 in the ATPase domain reduces the ATPase activity and abolishes the in vivo complementation ability.

Katherine L West1, Rosalind M Turnbull, Elaine Willmore, Jeremy H Lakey, Caroline A Austin.   

Abstract

We report for the first time an analysis of the ATPase activity of human DNA topoisomerase (topo) IIbeta. We show that topo IIbeta is a DNA-dependent ATPase that appears to fit Michaelis-Menten kinetics. The ATPase activity is stimulated 44-fold by DNA. The k(cat) for ATP hydrolysis by human DNA topo IIbeta in the presence of DNA is 2.25 s(-1). We have characterised a topo IIbeta derivative which carries a mutation in the ATPase domain (S165R). S165R reduced the kcat for ATP hydrolysis by 7-fold, to 0.32 s(-1), while not significantly altering the apparent K(m). The specificity constant for the interaction between ATP and topo IIbeta (kcat/K(mapp)) showed a 90% reduction for betaS165R. The DNA binding affinity and ATP-independent DNA cleavage activity of the enzyme are unaffected by this mutation. However, the strand passage activity is reduced by 80%, presumably due to reduced ATP hydrolysis. The mutant enzyme is unable to complement ts yeast topo II in vivo. We have used computer modelling to predict the arrangement of key residues at the ATPase active site of topo IIbeta. Ser165 is predicted to lie very close to the bound nucleotide, and the S165R mutation could thus influence both ATP binding and ADP dissociation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12490710      PMCID: PMC140051          DOI: 10.1093/nar/gkf677

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  41 in total

1.  The ATPase reaction cycle of yeast DNA topoisomerase II. Slow rates of ATP resynthesis and P(i) release.

Authors:  C L Baird; M S Gordon; D M Andrenyak; J F Marecek; J E Lindsley
Journal:  J Biol Chem       Date:  2001-05-15       Impact factor: 5.157

2.  The ATP-operated clamp of human DNA topoisomerase IIalpha: hyperstimulation of ATPase by "piggy-back" binding.

Authors:  Spencer Campbell; Anthony Maxwell
Journal:  J Mol Biol       Date:  2002-07-05       Impact factor: 5.469

3.  The DNA dependence of the ATPase activity of human DNA topoisomerase IIalpha.

Authors:  T R Hammonds; A Maxwell
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

4.  Topoisomerase II drives DNA transport by hydrolyzing one ATP.

Authors:  C L Baird; T T Harkins; S K Morris; J E Lindsley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

5.  Co-localization of chicken DNA topoisomerase IIalpha, but not beta, with sites of DNA replication and possible involvement of a C-terminal region of alpha through its binding to PCNA.

Authors:  A Niimi; N Suka; M Harata; A Kikuchi; S Mizuno
Journal:  Chromosoma       Date:  2001-05       Impact factor: 4.316

6.  Identifying Lys359 as a critical residue for the ATP-dependent reactions of Drosophila DNA topoisomerase II.

Authors:  T Hu; S Chang; T Hsieh
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

7.  Complementation of temperature-sensitive topoisomerase II mutations in Saccharomyces cerevisiae by a human TOP2 beta construct allows the study of topoisomerase II beta inhibitors in yeast.

Authors:  E L Meczes; K L Marsh; L M Fisher; M P Rogers; C A Austin
Journal:  Cancer Chemother Pharmacol       Date:  1997       Impact factor: 3.333

8.  ATPase domain of eukaryotic DNA topoisomerase II. Inhibition of ATPase activity by the anti-cancer drug bisdioxopiperazine and ATP/ADP-induced dimerization.

Authors:  Tao Hu; Harvey Sage; Tao-shih Hsieh
Journal:  J Biol Chem       Date:  2001-12-07       Impact factor: 5.157

9.  DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication.

Authors:  S DiNardo; K Voelkel; R Sternglanz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

10.  Dynamics of human DNA topoisomerases IIalpha and IIbeta in living cells.

Authors:  Morten O Christensen; Morten K Larsen; Hans Ullrich Barthelmes; Robert Hock; Claus L Andersen; Eigil Kjeldsen; Birgitta R Knudsen; Ole Westergaard; Fritz Boege; Christian Mielke
Journal:  J Cell Biol       Date:  2002-04-01       Impact factor: 10.539

View more
  7 in total

1.  Selectable high-yield recombinant protein production in human cells using a GFP/YFP nanobody affinity support.

Authors:  Matthew J Schellenberg; Robert M Petrovich; Christine C Malone; R Scott Williams
Journal:  Protein Sci       Date:  2018-04-17       Impact factor: 6.725

2.  Nitric oxide inhibits ATPase activity and induces resistance to topoisomerase II-poisons in human MCF-7 breast tumor cells.

Authors:  Birandra K Sinha; Ashutosh Kumar; Ronald P Mason
Journal:  Biochem Biophys Rep       Date:  2017-04-20

3.  Structure of a topoisomerase II-DNA-nucleotide complex reveals a new control mechanism for ATPase activity.

Authors:  Bryan H Schmidt; Neil Osheroff; James M Berger
Journal:  Nat Struct Mol Biol       Date:  2012-09-30       Impact factor: 15.369

4.  The impact of the human DNA topoisomerase II C-terminal domain on activity.

Authors:  Emma L Meczes; Kathryn L Gilroy; Katherine L West; Caroline A Austin
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

5.  Post-translational modifications in DNA topoisomerase 2α highlight the role of a eukaryote-specific residue in the ATPase domain.

Authors:  Claire Bedez; Christophe Lotz; Claire Batisse; Arnaud Vanden Broeck; Roland H Stote; Eduardo Howard; Karine Pradeau-Aubreton; Marc Ruff; Valérie Lamour
Journal:  Sci Rep       Date:  2018-06-18       Impact factor: 4.379

6.  A complex suite of loci and elements in eukaryotic type II topoisomerases determine selective sensitivity to distinct poisoning agents.

Authors:  Tim R Blower; Afif Bandak; Amy S Y Lee; Caroline A Austin; John L Nitiss; James M Berger
Journal:  Nucleic Acids Res       Date:  2019-09-05       Impact factor: 16.971

7.  Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue.

Authors:  Patrick Chène; Joëlle Rudloff; Joseph Schoepfer; Pascal Furet; Peter Meier; Zhiyan Qian; Jean-Marc Schlaeppi; Rita Schmitz; Thomas Radimerski
Journal:  BMC Chem Biol       Date:  2009-01-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.